A phase 1b lead-in to a randomized phase 2 trial of lurbinectedin plus doxorubicin in leiomyosarcoma (LMS) Meeting Abstract
| Authors: | Cote, G. M.; Choy, E.; Thornton, K. A.; Mazzola, E.; Bouberhan, S.; Merriam, P.; Wagner, A. J.; Morgan, J. A.; Haddox, C. L.; Oza, J.; Demetri, G. D.; George, S. |
| Abstract Title: | A phase 1b lead-in to a randomized phase 2 trial of lurbinectedin plus doxorubicin in leiomyosarcoma (LMS) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304800 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.TPS11592 |
| Notes: | Meeting Abstract: TPS11592 -- This meeting was also held virtually -- Source: Wos |
